SCHEMBL2311083

SCHEMBL2311083

Oc1ccc(C=Nc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 3/20 0.71
CA2 P00918 4/20 0.65
ALDH1A1 P00352 4/20 0.63
KDM4E B2RXH2 3/20 0.63
L3MBTL1 Q9Y468 3/20 0.63
MAPT P10636 3/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
BLM P54132 2/20 0.63
GAA P10253 1/20 0.63
THRB P10828 1/20 0.63
PKM P14618 1/20 0.63
CASP3 P42574 1/20 0.63
RECQL P46063 1/20 0.63
PLEC Q15149 1/20 0.63
SENP8 Q96LD8 1/20 0.63
SENP7 Q9BQF6 1/20 0.63
SENP6 Q9GZR1 1/20 0.63
DHODH Q02127 1/20 0.62
GLA P06280 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2311078 1.00 S100B (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
4-(Benzylideneamino)Phenol SCHEMBL1877533 0.91 S100B (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
4-(Benzylideneamino)Phenol SCHEMBL1877535 0.91 S100B (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
Phenol SCHEMBL3852646 0.91 S100B (0.61) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL15347676 0.89 CA2 (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL2839684 0.89 CA2 (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL14373623 0.89 CA2 (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL11320970 0.89 CA2 (0.71) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL14129042 0.89 ALDH1A1 (0.69) S100BCA2ALDH1A1KDM4EL3MBTL1
SCHEMBL59999 0.84 ALDH1A1 (0.63) S100BCA2ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115572346-A High-molecular absorbent with high flame retardance and preparation method thereof 应急管理部天津消防研究所 2023-01-06 CN claimed
CN-114573477-A Resveratrol imine analogue and preparation method and application thereof 西安医学院 2022-06-03 CN claimed
WO-2025084300-A1 IMINO-GROUP-CONTAINING BENZOXAZINE MONOMER AND CURABLE RESIN COMPOSITION 株式会社カネカ 2025-04-24 WO disclosed
CN-115572346-A High-molecular absorbent with high flame retardance and preparation method thereof 应急管理部天津消防研究所 2023-01-06 CN disclosed
CN-114573477-A Resveratrol imine analogue and preparation method and application thereof 西安医学院 2022-06-03 CN disclosed
US-10975307-B2 Liquid crystalline epoxy compound with terminal mesogen connected by flexible linkage and method for preparing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2021-04-13 US disclosed
US-20180201835-A1 LIQUID CRYSTALLINE EPOXY COMPOUND WITH TERMINAL MESOGEN CONNECTED BY FLEXIBLE LINKAGE AND METHOD FOR PREPARING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-07-19 US disclosed
CN-104910212-A Platinum schiff base complex and preparation method and application thereof UNIV SHANXI 2015-09-16 CN disclosed
US-8766004-B2 Green synthesis of aryl aldimines using ethyl lactate THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2014-07-01 US disclosed
US-20110196174-A1 GREEN SYNTHESIS OF ARYL ALDIMINES USING ETHYL LACTATE THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2011-08-11 US disclosed
CN-1206157-C Reversible molecular electronic device based on technique of scan tunnel microscope and its manufacturing method UNIV FUDAN (CN) 2005-06-15 CN disclosed
EP-0437105-A1 Intermediates and colorants having primary hydroxyl enriched poly(oxyalkylene) moieties and their preparation MILLIKEN RESEARCH CORPORATION (US) 1991-07-17 EP disclosed
US-4235929-A TOPICAL ADMINISTRATION OF ANTIINFLAMMATORY AGENT WILLIAM H. RORER, INC. (US) 1980-11-25 US disclosed
US-4224340-A Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds WILLIAM H. RORER, INC. (US) 1980-09-23 US disclosed
US-4214003-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1980-07-22 US disclosed
US-4214094-A ANTILIPEMIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-07-22 US disclosed
US-4198349-A ANTIINFLAMMATORY, TOPICAL WILLIAM H. RORER, INC. (US) 1980-04-15 US disclosed
US-4197314-A WITH A DIPHENYL NITRONE WILLIAM H. RORER, INC. (US) 1980-04-08 US disclosed
US-4176198-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1979-11-27 US disclosed
US-4153722-A ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE WILLIAM H. RORER, INC. (US) 1979-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196174-A1 GREEN SYNTHESIS OF ARYL ALDIMINES USING ETHYL LACTATE LDHA, LDHB, ALDOA S100B 2421/4885CA2 1478/4885ALDH1A1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.